logo
ProjectActive

Tridem Africa

The status, timeline and source of this project. A free account opens every field.

Source: International Finance Corporation (IFC)

Tridem Pharma SAS (“Tridem”), together with Guilin Pharma, are planning to expand their pharmaceutical production capacity and distribution capabilities in French-speaking Africa through the construction of a regional pharmaceutical distribution hub in Cote d’Ivoire and the greenfield construction of a local drug manufacturing facility in Cote d’Ivoire (the “Project”). The manufacturing facility i

Status
Prospective
Sector
Waste Processing and Treatment, Manufacturing (Industrial), Government
Location
Unknown (Sub-Saharan Africa)
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Tridem Africa

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

5 Q
The project “Tridem Africa” is an infrastructure initiative in the Waste Processing and Treatment sector, located in Africa Region. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

active

Taiyo status

Prospective

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Tridem Pharma SAS (“Tridem”), together with Guilin Pharma, are planning to expand their pharmaceutical production capacity and distribution capabilities in French-speaking Africa through the construction of a regional pharmaceutical distribution hub in Cote d’Ivoire and the greenfield construction of a local drug manufacturing facility in Cote d’Ivoire (the “Project”). The manufacturing facility in Cote d’Ivoire will primarily be used to manufacture life-saving anti-malaria drugs. The proposed IFC investment comprises of two A loans to the local subsidiaries of Tridem and Guilin Pharma for the implementation of the Project.Tridem is a French pharmaceutical distribution company with a substantial presence in Africa, which offers distribution solutions for pharmaceutical manufacturers, including regulatory affairs and licensing, promotion, distribution. Guilin Pharma is a Chinese pharmaceutical company and a leading producer of anti-malarial products, with its products being made available in over 80 countries globally.

Original sector

other

Budget

Location

Country

Unknown (Sub-Saharan Africa)

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Waste Processing and Treatment, Manufacturing (Industrial), Government

Article published date

2025-10-26

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project